March 2021 FDA Recall Drug by Cosette Pharmaceuticals, Inc.
D-0327-2021 - CGMP Deviaitons

This Class II drug recall was voluntarily initiated by Cosette Pharmaceuticals, Inc. on March 25, 2021 for the product Drug. The FDA reported the reason for recall as cgmp deviaitons. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0327-2021

Reason for Recall
CGMP Deviaitons
Initiated
03-25-2021
Reported
04-14-2021
Quantity
a) 30 mL: 7724 b) 60 mL: 8064 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Cosette Pharmaceuticals, Inc.
Nationwide in the US
Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080

Batch or Lot Expiration Information

Lot# a) 30 mL: 1014611 and 1014612, exp 12/2022 b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022